ZEISS microscope developers win the Deutscher Zukunftspreis 2022
The development of the ZEISS Lattice Lightsheet 7 for the gentle 3D imaging of living cells was honored with the German Federal President's Award for Technology and Innovation
Exploring the living cell
ZEISS Lattice Lightsheet 7 enables, for the first time, biomedical researchers to observe living cells live and in 3D for hours or even days. They study how, for example, the cells react to certain active agents, or what happens when viruses or bacteria enter cells. The problem for researchers studying living cells with fluorescence microscopes used to be the illumination: the intensities of the laser radiation used are higher than those of the sun by a factor of 1000 or more. This intense illumination can permanently damage living cells. A significant reduction in this photo damage is achieved with light sheet microscopy: unlike all other microscopes, the laser beam – in the form of a light sheet – is applied only in the area of the sample that is in the focus of the objective lens. To do this, the team had to tame the laser in a special way and completely rearrange the objective lenses because the cells grow on the cover slips in culture vessels like Petri dishes or multiwell plates. They developed a completely new type of microscope optic that enables a person to look through the sample vessels ‒ at an angle and from below ‒ at the cells inside without artifacts. All this has been developed into an easy-to-use, compact system with high potential for automation.
Innovation as part of the corporate identity
ZEISS has been nominated for the Deutscher Zukunftspreis multiple times. Two teams were even nominated in 2020. The ZEISS, TRUMPF and Fraunhofer research team was awarded the 2020 Federal President's Award for Technology and Innovation for the development of EUV lithography.
Innovation is a way of life at ZEISS. You might say it is in the company's genes. As part of corporate strategy, it is always associated with society as a whole – where it forms the basis for further growth within the ZEISS Group. That is why ZEISS invests 13 percent of its revenue in research and development work.
Optical technologies are vital when it comes to making progress in the life sciences, medicine, IT, telecommunications, automotive, consumer and many other fields. All ZEISS innovations aim to meet future customer needs with products, services, solutions and business models as well as offer added value and benefits.
The Deutscher Zukunftspreis 2022 was presented today by German President Frank-Walter Steinmeier in Berlin. Additional information about the award winners, the Prize and a link to the live stream can be found at www.deutscher-zukunftspreis.de/de/dzpwelt. ZDF will broadcast the award ceremony on 26 October at 10:15 p.m.
ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. The ZEISS Group generated annual revenue totaling more than 7.5 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (updated: 30 September 2021).
For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, as well as medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13% of its revenue in research and development work – ZEISS has a long tradition of high expenditure in these areas. This also represents the company's investment in the future.
With around 37,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 31 March 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG
Further information at www.zeiss.com